Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Prostatic Neoplasms 4 Brain Neoplasms 4 Neoplasms 3 Neoplasm Metastasis 3 Sarcoma 2 Multiple Myeloma 2 Lung Neoplasms 2 Glioma 2 Glioblastoma 2 Gastrointestinal Neoplasms 2 Fatigue 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Weight Loss 1 Uterine Cervical Neoplasms 1 Thrombocytopenia 1 Symptom Management 1 Stomach Neoplasms 1 Splenomegaly 1 Sexual Dysfunction, Physiological 1 Sex Cord-Gonadal Stromal Tumors 1 Sarcoma, Synovial 1 Rectal Neoplasms 1 Peritoneal Neoplasms 1 Pain 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neuroendocrine Tumors 1 Neoplasms, Germ Cell and Embryonal 1

Interventions

Ibandronic Acid 8 Gemcitabine 8 Doxorubicin 6 Cyclophosphamide 6 Zoledronic Acid 5 Radiation 4 Nivolumab 4 Irinotecan 4 pembrolizumab 3 Vincristine 3 Temozolomide 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Docetaxel 3 Cisplatin 3 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 3 regorafenib 2 pegfilgrastim 2 Tranexamic Acid 2 Trabectedin 2 Sunitinib 2 Standard of Care 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Radiosurgery 2 Proton Therapy 2 Methotrexate 2 Injections 2 Ifosfamide 2 Etoposide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Bone Neoplasms × Quality of Life × Clear all

NCT05051059 2026-03-16

QOLSarcoma

Universitaire Ziekenhuizen KU Leuven

Phase NA Recruiting

Bone Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡